FDA approves diabetes drug with evidence of superior blood sugar control
May 17, 2022
Mounjaro was more effective than other type 2 diabetes drugs at helping clinical trial participants control blood sugar and lose weight, the FDA reports.
Screen racial, ethnic groups at lower BMI levels for diabetes, researchers say
May 13, 2022
A newly vetted set of BMI diagnosis thresholds can help clinicians catch diabetes earlier in higher risk groups, investigators say.
Subjective cognitive impairment linked to MACE in T2DM
Apr 26, 2022
Among individuals with type 2 diabetes, country-standardized cognitive score may predict risk for cardiovascular events
Frail heart failure patients improve with common diabetes drug, trial finds
Apr 26, 2022
The SGLT2 inhibitor Farxiga substantially reduced risk for worsening heart failure events and death in frail patients, a new analysis finds. The more frail the patient, the more benefits seen.
Achieving treatment goals in T2DM can increase life expectancy
Apr 19, 2022
Life expectancy gains seen with reducing HbA1c, SBP, LDL-C, and BMI among individuals with type 2 diabetes
GLP-1 RA use may up risk for gallbladder, biliary diseases
Mar 31, 2022
GLP-1 RA treatment linked to increased risk, especially in trials for weight loss, and with higher doses and longer duration of use
Contested insulin therapy remains common in nursing homes: study
Apr 01, 2022
Despite being discouraged in the elderly, a facilities study has found that sliding scale insulin therapy is used in 21% of newly admitted residents who receive the drug for type 2 diabetes and is continued...
Overtreated diabetes raises hypoglycemia risk in nursing homes, investigators say
Mar 24, 2022
Fully 40% of residents with type 2 diabetes in a large VA nursing home study continued to receive insulin and other medications that increase hypoglycemia risk, even after their blood tests suggested overtreatment.
Feds expand Jardiance use to all heart failure patients
Feb 25, 2022
Originally approved as a glucose control drug for patients with type 2 diabetes, Jardiance has more recently proven effective in reducing mortality and hospitalization in some heart failure patients.
Obesity may increase end-stage kidney disease risk among those with type 2 diabetes
Feb 23, 2022
Higher body-mass index levels were associated with an increased risk of diabetic kidney disease and decreased kidney filtration rate levels in nearly 4,000 people with type 2 diabetes.